Keyphrases
Neuroinflammation
100%
Striatum
100%
Motor Performance
100%
Dopaminergic System
100%
Adenosine A2A Receptor Antagonist
100%
Rat Model of Parkinson's Disease
100%
KW-6002
100%
PET Scan
28%
Raclopride
28%
Motor Function
28%
Parkinson's Disease Model
28%
6-hydroxydopamine (6-OHDA)
28%
Post-mortem Analysis
28%
PBR28
28%
Dopaminergic Neuron Loss
28%
Inflammation
14%
PET Imaging
14%
Wistar Rats
14%
Receptor Antagonist
14%
Neuroprotective Effect
14%
Tyrosine Hydroxylase
14%
D2 Receptor
14%
Chronic Treatment
14%
Dopamine D2 Receptor (DRD2)
14%
Induced Damage
14%
Imaging Findings
14%
Motor Symptoms
14%
Vehicle Groups
14%
Adenosine A2A Receptor (A2AR)
14%
Iba1
14%
Rotarod Test
14%
Dopamine Receptor Availability
14%
Cylinder Test
14%
Medicine and Dentistry
Parkinson's Disease
100%
Adenosine
100%
Motor Performance
100%
Receptor Antagonist
100%
Striatum
100%
Neuroinflammation
100%
Dopaminergic System
100%
Istradefylline
100%
Carbon 11
57%
Positron Emission Tomography
42%
Symptom
28%
Contralateral
28%
Raclopride
28%
Dopaminergic Neuron
28%
Neuroprotective Agent
14%
Positron Emission Tomography
14%
Radioactive Tracer
14%
Tyrosine 3 Monooxygenase
14%
Dopamine Receptor
14%
Oxidopamine
14%
Pharmacology, Toxicology and Pharmaceutical Science
Rat Model
100%
Nervous System Inflammation
100%
Dopamine Receptor Stimulating Agent
100%
Parkinson's Disease
100%
Receptor Antagonist
100%
Adenosine
100%
Istradefylline
100%
Carbon 11
57%
Symptom
28%
Raclopride
28%
Inflammation
14%
Tracer
14%
Wistar Rat
14%
Neuroprotective Agent
14%
Dopamine Receptor
14%
Oxidopamine
14%
Tyrosine 3 Monooxygenase
14%
Neuroscience
Dopaminergic
100%
Parkinson's Disease
100%
Receptor Antagonist
100%
Striatum
100%
Adenosine A2A Receptor
100%
Istradefylline
100%
Positron Emission Tomography
42%
Raclopride
28%
Dopaminergic Neuron
28%
Neuroprotective Agent
14%
Tyrosine Hydroxylase
14%
Adenosine
14%
Oxidopamine
14%
Positron Emission Tomography
14%
Dopamine Receptor
14%